Randomized phase II trial of sorafenib (SO) with temsirolimus (TEM) or tipifarnib (TIPI) in metastatic melanoma: Southwest Oncology Group Trial S0438

Abstract only

Saved in:

Bibliographic Details
Published in	Journal of clinical oncology Vol. 28; no. 15_suppl; p. 8502
Main Authors	Margolin, K. A., Moon, J., Flaherty, L. E., Lao, C. D., Akerley, W. L., Sosman, J. A., Kirkwood, J. M., Sondak, V. K.
Format	Journal Article
Language	English
Published	20.05.2010
Online Access	Get full text

Loading…